Annovis Bio Inc盘中异动急速上涨5.90%报13.65美元_老虎社区_美港股上老虎

Annovis Bio Inc盘中异动急速上涨5.90%报13.65美元

自选股智能写手2022-07-18

北京时间2022年07月18日22时39分，Annovis Bio Inc（ANVS.us）股票出现异动，股价快速上涨5.90%。截至发稿，该股报13.65美元/股，成交量7548股，换手率0.09%，振幅3.49%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.89百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-6.19倍。机构评级方面，在所有2家参与评级的机构中，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

聰明的人做多
·2022-08-14
你好
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2252257325?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-07-18 22:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2252257325","market":"us","top_or_hot":-1,"title":"Annovis Bio Inc盘中异动 急速上涨5.90%报13.65美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2022年07月18日22时39分，Annovis Bio Inc（ANVS.us）股票出现异动，股价快速上涨5.90%。截至发稿，该股报13.65美元/股，成交量7548股，换手率0.09%，振幅3.49%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.89百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-6.19倍。机构评级方面，在所有2家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207182239328050db29&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annovis Bio Inc盘中异动 急速上涨5.90%报13.65美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnovis Bio Inc盘中异动 急速上涨5.90%报13.65美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-18 22:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207182239328050db29&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2022年07月18日22时39分，Annovis Bio Inc（ANVS.us）股票出现异动，股价快速上涨5.90%。截至发稿，该股报13.65美元/股，成交量7548股，换手率0.09%，振幅3.49%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.89百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-6.19倍。机构评级方面，在所有2家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207182239328050db29&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANVS","symbol_name":"Annovis Bio, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207182239328050db29&s=b","article_id":"2252257325","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207182239328050db29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2252257325","pubTimestamp":1658155171,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2022年07月18日22时39分，Annovis Bio Inc股票出现异动，股价快速上涨5.90%。截至发稿，该股报13.65美元/股，成交量7548股，换手率0.09%，振幅3.49%。Annovis Bio Inc股票所在的生物技术行业中，整体涨幅为0.13%。Annovis Bio Inc公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ANVS":"Annovis Bio, Inc.","BK4139":"生物科技"},"translate_title":"Annovis Bio Inc. jumped 5.90 percent to $13.65 in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANVS":0.9},"content_text":"北京时间2022年07月18日22时39分，Annovis Bio Inc（ANVS.us）股票出现异动，股价快速上涨5.90%。截至发稿，该股报13.65美元/股，成交量7548股，换手率0.09%，振幅3.49%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.89百万美元，每股收益-0.72美元，毛利0.00美元，市盈率-6.19倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Annovis Bio Inc股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Zivo Bioscience Inc C/Wts 14/05/2026 (To Pur Com)、Tc Biopharm (Holdings) Plc C/Wts 08/02/2028 (To Pur Ads)、Eqrx Inc C/Wts (To Pur Com)涨幅较大，Creative Medical Tech Holding Inc、Evofem Biosciences Inc、Eton Pharmaceuticals Inc较为活跃，换手率分别为30.55%、25.96%、18.60%，振幅较大的相关个股有Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)、Cellectar Biosciences Inc，振幅分别为48.33%、37.99%、24.33%。Annovis Bio Inc公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。公司管道产品有ANVS-401、ANVS-405、ANVS-301。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":684567220,"gmtCreate":1660476717964,"gmtModify":1660476717964,"author":{"id":"3476472488695615","authorId":"3476472488695615","name":"聰明的人做多","avatar":"https://static.tigerbbs.com/cb283203da58d2b01218c21d403896c0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3476472488695615","authorIdStr":"3476472488695615"},"htmlText":"你好","listText":"你好","text":"你好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/684567220","repostId":2252257325,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}